The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
Open accessAbstract
Alzheimer's disease (AD) characteristically presents with early memory loss. Regulation of K+channels, calcium homeostasis, and protein kinase C (PKC) activation are molecular events that have been implicated during associative memory which are also altered or defective in AD. PKC is also involved in the processing of the amyloid precursor protein (APP), a central element in AD pathophysiology. In previous studies, we demonstrated that benzolactam (BL), a novel PKC activator, reversed K+channels defects and enhanced secretion of APPα in AD cells. In this study we present data showing that another PKC activator, bryostatin 1, at subnanomolar concentrations dramatically enhances the secretion of the α-secretase product sAPPα in fibroblasts from AD patients. We also show that BL significantly increased the amount of sAPPα and reduced Aβ40 in the brains of APP[V717I] transgenic mice. In a more recently developed AD double-transgenic mouse, bryostatin was effective in reducing both brain Aβ40 and Aβ42. In addition, bryostatin ameliorated the rate of premature death and improved behavioral outcomes. Collectively, these data corroborate PKC and its activation as a potentially important means of ameliorating AD pathophysiology and perhaps cognitive impairment, thus offering a promising target for drug development. Because bryostatin 1 is devoid of tumor-promoting activity and is undergoing numerous clinical studies for cancer treatment in humans, it might be readily tested in patients as a potential therapeutic agent for Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Applications of the Morris water maze in the study of learning and memory
D’Hooge, R., & De Deyn, P. P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00067-4 · Cited by 2,040
Protein Kinase C: Structure, Function, and Regulation
Newton, A. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28495 · Cited by 1,655
Buxbaum, J. D., Liu, K.-N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., & Black, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27765 · Cited by 934
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
Self-citationIsolation and structure of bryostatin 1
Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., & Clardy, J. (1982) · Journal of the American Chemical Society · doi:10.1021/ja00388a092 · Cited by 653
A Portrait of Alzheimer Secretases--New Features and Familiar Faces
Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493
Blumberg, P. M. (1988) · PubMed · Cited by 428
Calcium-Mediated Reduction of Ionic Currents: A Biophysical Memory Trace
Alkon, D. L. (1984) · Science · doi:10.1126/science.6093258 · Cited by 393
Self-citationMeziane, H., Dodart, J.-C., Mathis, C., Little, S., Clemens, J., Paul, S. M., & Ungerer, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12683 · Cited by 357
Memory function in very early Alzheimer's disease
Petersen, R. C., Smith, G. E., Ivnik, R. J., Kokmen, E., & Tangalos, E. G. (1994) · Neurology · doi:10.1212/wnl.44.5.867 · Cited by 337
Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W., & Lee, V. M.-Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2568 · Cited by 328
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301
Vassar, R., & Citron, M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00051-9 · Cited by 299
Davidson, S. K., Allen, S. W., Lim, G. E., Anderson, C. M., & Haygood, M. G. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4531-4537.2001 · Cited by 275
Gschwendt, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00120.x · Cited by 243
Regulation of the α‐secretase ADAM10 by its prodomain and proprotein convertases
Anders, A., Gilbert, S., Garten, W., Postina, R., & Fahrenholz, F. (2001) · The FASEB Journal · doi:10.1096/fj.01-0007fje · Cited by 242
Szallasi, Z., Smith, C. B., Pettit, G. R., & Blumberg, P. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42143-0 · Cited by 240
Decreased levels of protein kinase C in Alzheimer brain
Cole, G., Dobkins, K. R., Hansen, L. A., Terry, R. D., & Saitoh, T. (1988) · Brain Research · doi:10.1016/0006-8993(88)90021-2 · Cited by 239
Dewachter, I., Reversé, D., Caluwaerts, N., Ris, L., Kuipéri, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03445.2002 · Cited by 237
Self-citationHennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., & Yuspa, S. H. (1987) · Carcinogenesis · doi:10.1093/carcin/8.9.1343 · Cited by 230
Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester
Savage, M. J., Trusko, S. P., Howland, D. S., Pinsker, L. R., Mistretta, S., Reaume, A. G., Greenberg, B. D., Siman, R., & Scott, R. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01743.1998 · Cited by 213
Chemistry and clinical biology of the bryostatins
Mutter, R., & Wills, M. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00150-4 · Cited by 178
Webb, B. L. J., Hirst, S. J., & Giembycz, M. A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703452 · Cited by 178
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Self-citationProtein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway
Garrido, J. L., Godoy, J., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0327fje · Cited by 163
Inhibition of β‐Amyloid Production by Activation of Protein Kinase C
Gabuzda, D. H., Busciglio, J. A., & Yankner, B. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07479.x · Cited by 155
A Preliminary Investigation of a Protein Kinase C Inhibitor in the Treatment of Acute Mania
Bebchuk, J. M., Arfken, C. L., Manji, S., Murphy, J., Hasanat, K., & Manji, H. K. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.95 · Cited by 152
Alkon, D. L., Nelson, T. J., Zhao, W., & Cavallaro, S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01277-6 · Cited by 132
Self-citationAttenuated protein kinase C activity and translocation in Alzheimer's disease brain.
Wang, H.-Y., Pisano, M. R., & Friedman, E. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90023-x · Cited by 122
Wender, P. A., Brabander, J. K. D., Harran, P. G., Jimenez, J., Koehler, M. F. T., Lippa, B., Park, C., Siedenbiedel, C., & Pettit, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6624 · Cited by 111
Dewachter, I., Dorpe, J. V., Smeijers, L., Gilis, M., Kuipéri, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06452.2000 · Cited by 108
Self-citationCytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients
Govoni, S. M., Bergamaschi, S., Racchi, M., Battaini, F., Binetti, G. G., Bianchetti, A., & Trabucchi, M. (1993) · Neurology · doi:10.1212/wnl.43.12.2581 · Cited by 105
Varterasian, M. L., Mohammad, R. M., Shurafa, M. S., Hulburd, K., Pemberton, P., Rodriguez, D. H., Spadoni, V., Eilender, D. S., Murgo, A. J., Wall, N. R., et al. (2000) · PubMed · Cited by 97
Favit, A., GRIMALDI, M., Nelson, T. J., & Alkon, D. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5562 · Cited by 82
Self-citationKinouchi, T., Sorimachi, H., Maruyama, K., Mizuno, K., Ohno, S., Ishiura, S., & Suzuki, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00392-m · Cited by 78
Pascale, A., Govoni, S. M., & Battaini, F. (1998) · Molecular Neurobiology · doi:10.1007/bf02740602 · Cited by 72
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 71
Suh, Y. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051781.x · Cited by 68
Yeon, S. W., Jung, M. W., Ha, M. J., Kim, S. U., Huh, K., Savage, M. J., Masliah, E., & Mook‐Jung, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4181 · Cited by 56
Amyloid β Peptide Formation in Cell-free Preparations
Desdouits, F., Buxbaum, J. D., Desdouits‐Magnen, J., Nairn, A. C., & Greengard, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24670 · Cited by 49
Kozikowski, A., Nowak, I., Petukhov, P., Etcheberrigaray, R., Mohamed, A., Tan, M., Lewin, N., Hennings, H., Pearce, L. L., & Blumberg, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020350r · Cited by 48
Self-citationAlzheimer’s Disease in Man and Transgenic Mice
Turner, R. S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64026-6 · Cited by 38
Pákáski, M., Baláspiri, L., Checler, F., & Kása, P. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00026-8 · Cited by 29
Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug
Zonder, J. A., & Philip, P. A. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2189 · Cited by 28
Potential novel targets for Alzheimer pharmacotherapy: I. Secretases
Maiorini, A. F., Gaunt, M., Jacobsen, T., McKay, A. E., Waldman, L., & Raffa, R. B. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00415.x · Cited by 26
Clarke, H., Ginanni, N., Laughlin, K. V., Smith, J. B., Pettit, G. R., & Mullin, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5035 · Cited by 23
Etcheberrigaray, R., & Bhagavan, S. (1999) · Molecular Neurobiology · doi:10.1007/bf02742436 · Cited by 21
Self-citationBhagavan, S., Ibarreta, D., Ma, D., Kozikowski, A. P., & Etcheberrigaray, R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0195 · Cited by 12
Self-citationProtein kinase C: a nexus in the biochemical events that underlie associative learning.
Olds, J. L., & Alkon, D. L. (1993) · PubMed · Cited by 11
Self-citation
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
100 Years and Counting: Prospects for Defeating Alzheimer's Disease
Roberson, E. D., & Mucke, L. (2006) · Science · doi:10.1126/science.1132813 · Cited by 550
NMDA receptors in clinical neurology: excitatory times ahead
Kalia, L. V., Kalia, S. K., & Salter, M. W. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70165-0 · Cited by 415
Natural products as a source of Alzheimer's drug leads
Williams, P., Sorribas, A., & Howes, M.-J. R. (2011) · Nat. Prod. Rep. · doi:10.1039/c0np00027b · Cited by 404
Metadata
- Authors
- Etcheberrigaray, R., Tan, M., Dewachter, I., Kuipéri, C., Van der Auwera, I., Wera, S., Qiao, L., Bank, B., Nelson, T. J., Kozikowski, A. P., Van Leuven, F., & Alkon, D. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-07-19
- Volume
- 101
- Issue
- 30
- Pages
- 11141-11146
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2063661531
- Cited by
- 342
- References
- 51
- FWCI
- 11.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.